Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-22-005681

Chief Financial Officer sold 4,800 shares at an average $30.01 ($144,028)

From the SEC's structured data for this filing

Trades in this filing

Vasista Vittal · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-07-13 Sale : show line 1 in the form −4,332 $30.01 $129,988 158,108 D
2022-07-14 Sale : show line 2 in the form −468 $30.00 $14,040 157,640 D
Open-market sales · 4,800 sh · avg $30.01 · $144,028
Loading xslF345X03/primarydocument.xml…